Status:
COMPLETED
Intravitreal Triamcinolone for Acute Branch Retinal Vein Occlusion
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Branch Retinal Vein Occlusion
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine whether intraocular injection of triamcinolone is effective in the treatment of macular edema in acute branch retinal vein occlusion.
Detailed Description
Intravitreal triamcinolone has recently been shown to have beneficial effect on chronic macular edema due to vein occlusion and preventive effect on neovascularization. Hypothetically, prevention of m...
Eligibility Criteria
Inclusion
- Eyes suffering from branch retinal vein occlusion with less than 2 months duration.
Exclusion
- Monocularity,
- Previous intraocular surgery or laser therapy
- Glaucoma or ocular hypertension
- Significant media opacity
- Existence of traction on the macula
- Visual acuity ≥20/40
- Signs of chronicity (such as cilioretinal and/or retinal shunt vessels)
Key Trial Info
Start Date :
February 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2007
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00370266
Start Date
February 1 2003
End Date
December 1 2007
Last Update
June 17 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alireza Ramezani, MD
Tehran, Tehran Province, Iran, 16666